NCT01489241.

Methods	Study design: unknown centres, single‐blinded, parallel individual randomised controlled trial in Greece Duration: 12 weeks Setting: hospitals
Participants	Population: 155 adults recruited from Central Greece Baseline characteristics: unknown Inclusion criteria: ≥ 40 years, able to use devices for study, willing to participate, COPD per GOLD guidelines Exclusion criteria: involved in previous COPD monitoring study
Interventions	Measurements taken at baseline and at 3 months Treatment arms Phone‐based telemonitoring platform Data sent to telehealth centre
Outcomes	Primary outcomes: hospital readmissions Secondary outcomes: QOL SF‐36, HADS, SGRQ, FEV₁, mortality, patient satisfaction survey
Notes	Funding: Regional Health Authority of Sterea & Thessaly Other identifier:NCT01489241